Cargando…

126 novel mutations in Italian patients with neurofibromatosis type 1

Genetic analysis of Neurofibromatosis type 1 (NF1) may facilitate the identification of patients in early phases of the disease. Here, we present an overview of our diagnostic research spanning the last 11 years, with a focus on the description of 225 NF1 mutations, 126 of which are novel, found in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bianchessi, Donatella, Morosini, Sara, Saletti, Veronica, Ibba, Maria Cristina, Natacci, Federica, Esposito, Silvia, Cesaretti, Claudia, Riva, Daria, Finocchiaro, Gaetano, Eoli, Marica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694136/ https://www.ncbi.nlm.nih.gov/pubmed/26740943 http://dx.doi.org/10.1002/mgg3.161

Ejemplares similares

Non-Coding RNA and Tumor Development in Neurofibromatosis Type 1: ANRIL Rs2151280 Is Associated with Optic Glioma Development and a Mild Phenotype in Neurofibromatosis Type 1 Patients
por: Tritto, Viviana, et al.
Publicado: (2019)

Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype–Phenotype Correlations in a Large Independent Cohort
por: Melloni, Giulia, et al.
Publicado: (2019)

Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients
por: Bianchessi, Donatella, et al.
Publicado: (2020)

A Translational Approach to Spinal Neurofibromatosis: Clinical and Molecular Insights from a Wide Italian Cohort
por: Paterra, Rosina, et al.
Publicado: (2022)

Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres
por: Patanè, Monica, et al.
Publicado: (2013)

NEDD9, a novel target of miR-145, increases the invasiveness of glioblastoma
por: Speranza, Maria Carmela, et al.
Publicado: (2012)

Visuoperceptual Impairment in Children with NF1: From Early Visual Processing to Procedural Strategies
por: Bulgheroni, Sara, et al.
Publicado: (2019)

Brain Tumors in NF1 Children: Influence on Neurocognitive and Behavioral Outcome
por: Taddei, Matilde, et al.
Publicado: (2019)

ABCC3 Expressed by CD56(dim) CD16(+) NK Cells Predicts Response in Glioblastoma Patients Treated with Combined Chemotherapy and Dendritic Cell Immunotherapy
por: Pellegatta, Serena, et al.
Publicado: (2019)

Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment against Glioblastoma
por: Cuccarini, Valeria, et al.
Publicado: (2019)

Parametric Response Maps of Perfusion MRI May Identify Recurrent Glioblastomas Responsive to Bevacizumab and Irinotecan
por: Aquino, Domenico, et al.
Publicado: (2014)

First TMEM126A missense mutation in an Italian proband with optic atrophy and deafness
por: La Morgia, Chiara, et al.
Publicado: (2019)

A Subpopulation of Circulating Endothelial Cells Express CD109 and is Enriched in the Blood of Cancer Patients
por: Mancuso, Patrizia, et al.
Publicado: (2014)

The Contribution of Oxidative Stress to NF1-Altered Tumors
por: Kuhn, Elisabetta, et al.
Publicado: (2023)

Characterization of 22q12 Microdeletions Causing Position Effect in Rare NF2 Patients with Complex Phenotypes
por: Tritto, Viviana, et al.
Publicado: (2022)

Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1
por: Stella, Alessandro, et al.
Publicado: (2018)

The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1
por: Cervi, Francesca, et al.
Publicado: (2020)

The Lipid Asset Is Unbalanced in Peripheral Nerve Sheath Tumors
por: Vetrano, Ignazio G., et al.
Publicado: (2021)

Early tumour shrinkage as a survival predictor in patients with recurrent glioblastoma treated with bevacizumab in the AVAREG randomized phase II study
por: Brandes, Alba A., et al.
Publicado: (2017)

At S126
por: CERN PhotoLab
Publicado: (1974)

At S126
por: CERN PhotoLab
Publicado: (1974)

Polysomnographic study in pediatric neurofibromatosis type 1
por: Carotenuto, Marco, et al.
Publicado: (2023)

Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide in Recurrent Glioblastoma Patients: Real-World Experience from a Multicenter Study of Italian Association of Neuro-Oncology (AINO)
por: Padovan, Marta, et al.
Publicado: (2021)

IL-1R8 as Pathoimmunological Marker for Severity of Canine Chronic Enteropathy
por: Riva, Federica, et al.
Publicado: (2022)

Prognostic Value of CD109+ Circulating Endothelial Cells in Recurrent Glioblastomas Treated with Bevacizumab and Irinotecan
por: Cuppini, Lucia, et al.
Publicado: (2013)

Legius Syndrome: two novel mutations in the SPRED1 gene
por: Bianchi, Marika, et al.
Publicado: (2015)

Revisiting the Immunological Aspects of Temozolomide Considering the Genetic Landscape and the Immune Microenvironment Composition of Glioblastoma
por: Di Ianni, Natalia, et al.
Publicado: (2021)

Cognitive and Behavioral Outcome of Pediatric Low-Grade Central Nervous System Tumors Treated Only with Surgery: A Single Center Experience
por: Taddei, Matilde, et al.
Publicado: (2023)

miR-126 and miR-126*: New Players in Cancer
por: Meister, Jeannette, et al.
Publicado: (2010)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

A magnet for S126
Publicado: (1974)

Wire chambers for S126
Publicado: (1974)

126 Stones in the Bladder
por: Daruvala, Bamanji Pestanji
Publicado: (1912)

Neurofibromatosis
por: Gerber, PA, et al.
Publicado: (2009)

Neurofibromatosis
por: Hovinga, Koos E., et al.
Publicado: (2020)

The natural killer cell response and tumor debulking are associated with prolonged survival in recurrent glioblastoma patients receiving dendritic cells loaded with autologous tumor lysates
por: Pellegatta, Serena, et al.
Publicado: (2013)

Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006)
por: Masocco, Maria, et al.
Publicado: (2011)

Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study
por: Lessi, Federica, et al.
Publicado: (2021)

Early neonatal Glutaric aciduria type I hidden by perinatal asphyxia: a case report
por: Biasucci, Giacomo, et al.
Publicado: (2018)

MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses
por: Tomasetti, Marco, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5c8kb1bj2qi4bi1qkf3dm0ivod